The “oraCle” project ranks first – approved for funding

In July 2017 Transactiva directed, as leader, a public-private partnership for the participation in the POR FESR 2014-2020 calls, (Activity 1.3.b) – for “R&D projects to be achieved through public-private partnerships – areas of specialization Maritime Technologies and Smart Health”.

The project “A new integrated approach for oral therapy of Crohn’s disease: oraCle” was presented as a strategic project in the Smart Health area. Project partners are Turval Laboratori Italia Srl, Biofarma Spa and the Universities of Udine and Trieste. More information about the oraCle project are available in the dedicated section of our site.

With great satisfaction of all the involved partners, the oraCle project ranked first in the list of projects approved for funding, which is available at this link, for a total funding of €877,360.29.

The “oraCle” project ranks first – approved for funding
Tagged on: